NASDAQ:SAGE
Sage Therapeutics
- Stock
Last Close
6.30
12/11 21:00
Market Cap
663.81M
Beta: 1.15
Volume Today
563.59K
Avg: 531.49K
PE Ratio
−2.29
PFCF: −2.65
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -9.25M - | -41.50M 348.46% | -31.58M 23.90% | |||||||||
average payables | 1.65M - | 2.21M 33.77% | 3.79M 71.79% | 8.99M 136.90% | 11.08M 23.31% | 21.69M 95.72% | 24.65M 13.64% | 9.48M 61.55% | 7.07M 25.40% | 14.70M 107.91% | 14.63M 0.45% | |
average receivables | 9.25M - | 16.08M 73.81% | 48.33M 200.53% | |||||||||
book value per share | -1.88 - | 5.65 400.50% | 6.25 10.68% | 11.00 75.96% | 12.48 13.38% | 18.71 49.99% | 18.58 0.68% | 39.87 114.52% | 29.47 26.08% | 21.12 28.33% | 13.36 36.74% | |
capex per share | -0.00 - | -0.01 3,217.39% | -0.01 20.14% | -0.04 495.23% | -0.04 15.90% | -0.06 73.78% | -0.11 82.44% | -0.01 94.13% | -0.01 4.46% | -0.02 149.18% | -0.01 41.50% | |
capex to depreciation | -0.06 - | -2.51 3,832.03% | -1.72 31.40% | -5.06 193.71% | -2.56 49.35% | -2.50 2.30% | -2.52 0.67% | -0.13 94.79% | -0.09 32.19% | -0.84 838.83% | -0.40 52.46% | |
capex to operating cash flow | 0.00 - | 0.00 2,663.66% | 0.00 40.82% | 0.01 327.43% | 0.01 48.20% | 0.01 76.90% | 0.01 0.86% | -0.00 104.77% | 0.00 289.40% | 0.00 107.06% | 0.00 49.78% | |
capex to revenue | -0.03 - | -0.84 2,543.05% | -0.00 99.96% | -0.06 18,945.63% | -0.12 106.72% | -0.01 94.75% | ||||||
cash per share | 0.48 - | 5.92 1,131.59% | 6.72 13.52% | 11.87 76.52% | 13.61 14.71% | 20.01 46.97% | 19.84 0.85% | 40.39 103.60% | 29.70 26.47% | 21.46 27.75% | 12.59 41.34% | |
days of inventory on hand | -12.21K - | -28.95K 137.02% | 225.19 100.78% | |||||||||
days payables outstanding | 13.93K - | 2.38K 82.88% | 6.90K 189.26% | 8.51K 23.35% | 1.74K 79.50% | |||||||
days sales outstanding | 1.07K - | 648.70 39.42% | 350.45 45.98% | |||||||||
debt to assets | 0.03 - | 0.01 61.96% | 0.01 22.40% | 0.01 11.42% | 0.01 34.56% | |||||||
debt to equity | 0.04 - | 0.01 65.47% | 0.01 21.38% | 0.01 9.13% | 0.01 33.31% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.04 - | -0.04 18.26% | -0.06 36.27% | -0.09 59.33% | -0.04 53.72% | -0.08 96.15% | -0.18 109.91% | 0.13 176.07% | -0.18 234.03% | -0.22 23.18% | -0.42 87.69% | |
enterprise value | 496.84M - | 661.86M 33.21% | 1.43B 116.47% | 1.54B 7.60% | 5.97B 287.35% | 4.23B 29.21% | 3.58B 15.30% | 2.86B 20.00% | 2.22B 22.49% | 2.11B 4.89% | 1.23B 41.70% | |
enterprise value over ebitda | -27.25 - | -19.58 28.17% | -15.14 22.67% | -9.63 36.41% | -21.86 127.12% | -10.75 50.83% | -5.06 52.97% | 4.39 186.93% | -4.82 209.60% | -3.86 19.86% | -2.41 37.68% | |
ev to operating cash flow | -28.36 - | -24.48 13.71% | -20.27 17.18% | -12.99 35.92% | -27.23 109.64% | -16.22 40.45% | -6.77 58.24% | 4.31 163.67% | -5.87 236.15% | -4.59 21.82% | -2.28 50.39% | |
ev to sales | 46.82 - | 521.27 1,013.24% | 2.57 99.51% | 351.94 13,591.30% | 274.70 21.95% | 14.24 94.82% | ||||||
free cash flow per share | -1.04 - | -1.26 20.58% | -2.55 102.61% | -3.59 40.53% | -5.79 61.44% | -5.71 1.30% | -10.51 84.00% | 12.77 221.48% | -6.45 150.52% | -7.77 20.47% | -9.04 16.35% | |
free cash flow yield | -0.03 - | -0.03 0.83% | -0.04 27.20% | -0.07 60.46% | -0.04 49.95% | -0.06 69.72% | -0.15 144.16% | 0.15 201.37% | -0.15 202.73% | -0.20 34.36% | -0.42 104.78% | |
graham net net | -1.91 - | 5.56 391.51% | 6.17 10.97% | 10.79 74.88% | 12.18 12.90% | 18.06 48.24% | 17.09 5.37% | 38.72 126.51% | 28.13 27.33% | 19.33 31.28% | 12.26 36.61% | |
graham number | 6.79 - | 14.11 107.88% | 21.88 55.00% | 34.28 56.70% | 44.60 30.11% | 58.34 30.80% | 73.13 25.35% | 102.26 39.84% | 71.38 30.20% | 63.50 11.04% | 52.16 17.86% | |
income quality | 0.96 - | 0.80 16.53% | 0.75 6.48% | 0.75 0.20% | 0.81 8.75% | 0.70 13.88% | 0.78 11.18% | 1.10 41.02% | 0.83 24.65% | 0.86 4.54% | 1.00 15.62% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -4.23K - | -38.55 - | ||||||||||
interest debt per share | 0.00 - | 0.73 - | 0.54 25.92% | 0.31 41.88% | 0.44 41.29% | 0.09 80.55% | ||||||
inventory turnover | -0.03 - | -0.01 57.81% | 1.62 12,956.52% | |||||||||
invested capital | 0.04 - | 0.01 65.47% | 0.01 21.38% | 0.01 9.13% | 0.01 33.31% | |||||||
market cap | 504.91M - | 789.62M 56.39% | 1.62B 105.10% | 1.71B 5.60% | 6.28B 267.09% | 4.42B 29.62% | 3.67B 16.94% | 4.50B 22.55% | 2.50B 44.50% | 2.26B 9.37% | 1.30B 42.67% | |
net current asset value | -31.66M - | 121.04M 482.31% | 173.17M 43.07% | 366.56M 111.68% | 470.61M 28.38% | 854.96M 81.67% | 895.60M 4.75% | 2.04B 127.27% | 1.70B 16.27% | 1.17B 31.43% | 786.60M 32.69% | |
net debt to ebitda | 0.44 - | 3.78 754.17% | 1.97 47.79% | 1.05 46.67% | 1.12 6.55% | 0.49 56.69% | 0.13 73.94% | -2.51 2,079.99% | 0.60 123.88% | 0.28 54.00% | 0.13 53.26% | |
net income per share | -1.09 - | -1.57 43.80% | -3.40 117.06% | -4.75 39.54% | -7.09 49.30% | -8.08 14.08% | -12.79 58.19% | 11.66 191.16% | -7.68 165.91% | -8.49 10.44% | -9.05 6.64% | |
operating cash flow per share | -1.04 - | -1.25 20.04% | -2.54 103.00% | -3.54 39.26% | -5.75 62.37% | -5.65 1.76% | -10.40 84.02% | 12.78 222.86% | -6.45 150.44% | -7.76 20.34% | -9.03 16.47% | |
payables turnover | 0.03 - | 0.15 484.21% | 0.05 65.43% | 0.04 18.93% | 0.21 387.73% | |||||||
receivables turnover | 0.34 - | 0.56 65.07% | 1.04 85.10% | |||||||||
research and ddevelopement to revenue | 3.13 - | 53.70 1,618.39% | 0.26 99.51% | 44.89 16,987.13% | 42.44 5.47% | 4.12 90.29% | ||||||
return on tangible assets | -2.14 - | -0.26 87.83% | -0.50 91.72% | -0.39 21.39% | -0.51 29.69% | -0.39 23.21% | -0.60 53.22% | 0.28 146.81% | -0.25 187.99% | -0.37 50.22% | -0.61 65.42% | |
revenue per share | 1.96 - | 0.14 93.10% | 21.43 15,764.37% | 0.11 99.50% | 0.13 20.54% | 1.44 1,014.87% | ||||||
roe | 0.58 - | -0.28 147.85% | -0.54 96.12% | -0.43 20.70% | -0.57 31.68% | -0.43 23.94% | -0.69 59.28% | 0.29 142.49% | -0.26 189.15% | -0.40 54.09% | -0.68 68.57% | |
roic | -0.28 - | -0.54 96.18% | -0.43 20.75% | -0.57 31.64% | -0.48 15.21% | -0.66 38.23% | 0.27 141.09% | -0.26 194.15% | -0.40 57.46% | -0.71 75.19% | ||
sales general and administrative to revenue | 2.23 - | 50.35 2,156.61% | 0.18 99.65% | 29.09 16,356.69% | 29.63 1.84% | 3.18 89.28% | ||||||
shareholders equity per share | -1.88 - | 5.65 400.50% | 6.25 10.68% | 11.00 75.96% | 12.48 13.38% | 18.71 49.99% | 18.58 0.68% | 39.87 114.52% | 29.47 26.08% | 21.12 28.33% | 13.36 36.74% | |
stock based compensation to revenue | 1.13 - | 22.31 1,875.29% | 0.09 99.61% | 16.59 19,152.16% | 8.01 51.68% | 0.85 89.41% | ||||||
tangible asset value | -31.54M - | 121.89M 486.49% | 173.69M 42.51% | 368.52M 112.16% | 475.48M 29.02% | 862.97M 81.50% | 944.65M 9.47% | 2.07B 119.37% | 1.73B 16.57% | 1.25B 27.55% | 799.53M 36.17% | |
tangible book value per share | -1.88 - | 5.65 400.50% | 6.25 10.68% | 11.00 75.96% | 12.48 13.38% | 18.71 49.99% | 18.58 0.68% | 39.87 114.52% | 29.47 26.08% | 21.12 28.33% | 13.36 36.74% | |
working capital | 6.09M - | 121.06M 1,887.28% | 173.18M 43.05% | 367.41M 112.15% | 473.12M 28.77% | 858.66M 81.49% | 922.97M 7.49% | 2.06B 122.67% | 1.72B 16.53% | 1.17B 31.61% | 786.60M 32.95% |
All numbers in USD (except ratios and percentages)